- Home
- JSPR vs ICCM Comparison
JSPR vs ICCM Comparison
Compare JSPR & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JSPR | ICCM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 43.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | JSPR | ICCM |
|---|---|---|
| Price | $1.37 | $0.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $18.13 | $2.50 |
| AVG Volume (30 Days) | ★ 395.8K | 136.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $0.54 |
| 52 Week High | $7.19 | $1.53 |
Technical Indicators
Market Signals| Indicator | JSPR | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 49.55 |
| Support Level | $1.30 | $0.59 |
| Resistance Level | $1.44 | $0.62 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 55.56 | 45.31 |
Price Performance
Historical ComparisonAbout JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.